Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raghida A Bukhalid

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Molecular Microbiology|February 3, 2005
A large, mobile pathogenicity island confers plant pathogenicity on Streptomyces speciesJohan A Kers, Kimberly D Cameron, Madhumita V Joshi, et al.
Nature|May 7, 2004
Nitration of a peptide phytotoxin by bacterial nitric oxide synthaseJohan A Kers, Michael J Wach, Stuart B Krasnoff, et al.
Journal of Medicinal Chemistry|July 24, 2023
Discovery and Optimization of a STING Agonist Platform for Application in Antibody Drug ConjugatesJeremy R Duvall, Joshua D Thomas, Raghida A Bukhalid, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 3, 2025
XMT-2056, a HER2-Directed STING Agonist Antibody-Drug Conjugate, Induces Innate Antitumor Immune Responses by Acting on Cancer Cells and Tumor-Resident Immune CellsRaghida A Bukhalid, Jeremy R Duvall, Kelly Lancaster, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Molecular Microbiology|February 3, 2005
A large, mobile pathogenicity island confers plant pathogenicity on Streptomyces speciesJohan A Kers, Kimberly D Cameron, Madhumita V Joshi, et al.
Nature|May 7, 2004
Nitration of a peptide phytotoxin by bacterial nitric oxide synthaseJohan A Kers, Michael J Wach, Stuart B Krasnoff, et al.
Journal of Medicinal Chemistry|July 24, 2023
Discovery and Optimization of a STING Agonist Platform for Application in Antibody Drug ConjugatesJeremy R Duvall, Joshua D Thomas, Raghida A Bukhalid, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 3, 2025
XMT-2056, a HER2-Directed STING Agonist Antibody-Drug Conjugate, Induces Innate Antitumor Immune Responses by Acting on Cancer Cells and Tumor-Resident Immune CellsRaghida A Bukhalid, Jeremy R Duvall, Kelly Lancaster, et al.
Pageof 1